Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma.

Eissa S, Kenawy G, Swellam M, El-Fadle AA, Abd El-Aal AA, El-Ahmady O.

Clin Biochem. 2004 Sep;37(9):803-10.

PMID:
15329320
2.

Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer.

Shabayek MI, Sayed OM, Attaia HA, Awida HA, Abozeed H.

Pathol Oncol Res. 2014 Oct;20(4):859-66. doi: 10.1007/s12253-014-9765-y. Epub 2014 Apr 3.

PMID:
24696417
3.

Mucin 7 and cytokeratin 20 as new diagnostic urinary markers for bladder tumor.

Retz M, Lehmann J, Amann E, Wullich B, Röder C, Stöckle M.

J Urol. 2003 Jan;169(1):86-9.

PMID:
12478110
4.
5.

Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.

Southgate J, Lobban D, Harnden P.

Cancer. 1998 Sep 1;83(5):1052-4. No abstract available.

PMID:
9731913
6.

A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.

Eissa S, Swellam M, Labib RA, El-Zayat T, El Ahmady O.

J Urol. 2009 Mar;181(3):1353-60. doi: 10.1016/j.juro.2008.10.102. Epub 2009 Jan 29.

PMID:
19185322
7.

Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.

Eissa S, Kassim SK, Labib RA, El-Khouly IM, Ghaffer TM, Sadek M, Razek OA, El-Ahmady O.

Cancer. 2005 Apr 1;103(7):1356-62.

8.

Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer.

Eissa S, Zohny SF, Swellam M, Mahmoud MH, El-Zayat TM, Salem AM.

Clin Biochem. 2008 Nov;41(16-17):1335-41. doi: 10.1016/j.clinbiochem.2008.08.085. Epub 2008 Sep 9.

PMID:
18804101
9.

Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer.

Abd El Gawad IA, Moussa HS, Nasr MI, El Gemae EH, Masooud AM, Ibrahim IK, El Hifnawy NM.

J Egypt Natl Canc Inst. 2005 Sep;17(3):193-202.

10.

Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.

Shariat SF, Herman MP, Casella R, Lotan Y, Karam JA, Stenman UH.

Eur Urol. 2005 Sep;48(3):424-31.

PMID:
15963628
11.

The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.

Siracusano S, Niccolini B, Knez R, Tiberio A, Benedetti E, Bonin S, Ciciliato S, Pappagallo GL, Belgrano E, Stanta G.

Eur Urol. 2005 Mar;47(3):327-33. Epub 2004 Dec 2.

PMID:
15716196
12.

Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence.

Eissa S, Zohny SF, Zekri AR, El-Zayat TM, Maher AM.

Med Oncol. 2010 Dec;27(4):1286-94. doi: 10.1007/s12032-009-9375-9. Epub 2009 Dec 11.

PMID:
20012564
13.

Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: relation to bilharziasis.

Eissa S, Matboli M, Mansour A, Mohamed S, Awad N, Kotb YM.

Med Oncol. 2014 Feb;31(2):804. doi: 10.1007/s12032-013-0804-4. Epub 2013 Dec 28.

PMID:
24375315
14.

Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.

Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.

Urology. 2004 Jul;64(1):157-61.

PMID:
15245962
15.

Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.

Bialkowska-Hobrzanska H, Bowles L, Bukala B, Joseph MG, Fletcher R, Razvi H.

Mol Diagn. 2000 Dec;5(4):267-77.

PMID:
11172490
17.

Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer.

Golijanin D, Shapiro A, Pode D.

J Urol. 2000 Dec;164(6):1922-5.

PMID:
11061882
18.

Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?

Buchumensky V, Klein A, Zemer R, Kessler OJ, Zimlichman S, Nissenkorn I.

J Urol. 1998 Dec;160(6 Pt 1):1971-4.

PMID:
9817302
20.

The clinical relevance of urine-based markers for diagnosis of bladder cancer.

Eissa S, Swellam M, Amin A, Balbaa ME, Yacout GA, El-Zayat TM.

Med Oncol. 2011 Jun;28(2):513-8. doi: 10.1007/s12032-010-9422-6. Epub 2011 Mar 25.

PMID:
21437743

Supplemental Content

Support Center